High unbound fraction of salicylate in plasma during intoxication.
作者信息
Alván G, Bergman U, Gustafsson L L
出版信息
Br J Clin Pharmacol. 1981 Jun;11(6):625-6. doi: 10.1111/j.1365-2125.1981.tb01182.x.
Abstract
摘要
相似文献
1
High unbound fraction of salicylate in plasma during intoxication.中毒期间血浆中水杨酸的游离分数高。
Br J Clin Pharmacol. 1981 Jun;11(6):625-6. doi: 10.1111/j.1365-2125.1981.tb01182.x.
2
Delayed Salicylate Toxicity in a 17-Year-Old Girl With Initially Undetectable Salicylate Concentration 3.9 Hours After Ingestion.一名17岁女孩摄入水杨酸后3.9小时初始水杨酸浓度无法检测，出现延迟性水杨酸盐中毒。
Pediatr Emerg Care. 2017 Nov;33(11):e126-e127. doi: 10.1097/PEC.0000000000000859.
3
Delayed coma associated with salicylate intoxication.
J Pediatr. 1982 Mar;100(3):493-6. doi: 10.1016/s0022-3476(82)80468-x.
4
Salicylate clearance, the resultant of protein binding and metabolism.水杨酸盐清除率，是蛋白质结合和代谢的结果。
Clin Pharmacol Ther. 1979 Sep;26(3):380-9. doi: 10.1002/cpt1979263380.
5
The risk of severe salicylate poisoning following the ingestion of topical medicaments or aspirin.摄入外用药物或阿司匹林后发生严重水杨酸盐中毒的风险。
Postgrad Med J. 1996 Feb;72(844):109-12. doi: 10.1136/pgmj.72.844.109.
6
Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers.正常志愿者中水杨酸盐诱导耳毒性的浓度-反应关系。
Br J Clin Pharmacol. 1989 Dec;28(6):695-702. doi: 10.1111/j.1365-2125.1989.tb03562.x.
7
Misleading results in cases of coexisting acetaminophen and salicylate overdose.
Clin Chem. 1980 Apr;26(5):673-4.
8
Salicylate intoxication in infancy: a review.
S Afr Med J. 1975 Mar 8;49(10):349-53.
9
Forced diuresis in the treatment of acute salicylate poisoning in adults.
Q J Med. 1969 Jan;38(149):31-48.
10
Salicylate intoxication in an adult.成人水杨酸盐中毒
AMA Arch Intern Med. 1958 Aug;102(2):213-6. doi: 10.1001/archinte.1958.00260200041008.
引用本文的文献
1
Guidance document: management priorities in salicylate toxicity.指导文件：水杨酸盐中毒的管理重点
J Med Toxicol. 2015 Mar;11(1):149-52. doi: 10.1007/s13181-013-0362-3.
2
Rationale for monitoring free drug levels.监测游离药物水平的基本原理。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:1-9. doi: 10.2165/00003088-198400091-00001.
3
A reassessment of the treatment of salicylate poisoning.水杨酸盐中毒治疗的重新评估
Drug Saf. 1992 Jul-Aug;7(4):292-303. doi: 10.2165/00002018-199207040-00005.
本文引用的文献
1
Pharmacokinetics of salicylate elimination in man.人体中水杨酸盐消除的药代动力学。
J Pharm Sci. 1965 Jul;54(7):959-67. doi: 10.1002/jps.2600540703.
2
Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.血浆蛋白药物结合的年龄差异：对人类胎儿、新生儿和成年人的研究。
Eur J Clin Pharmacol. 1971 Sep;3(4):189-93. doi: 10.1007/BF00565004.
3
Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.
Clin Pharmacol Ther. 1972 Mar-Apr;13(2):258-68. doi: 10.1002/cpt1972132258.
4
Protein binding of salicylate in uremic and normal plasma.尿毒症血浆和正常血浆中水杨酸盐的蛋白质结合情况。
Clin Pharmacol Ther. 1976 Oct;20(4):464-75. doi: 10.1002/cpt1976204464.
5
Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels.人血清白蛋白与水杨酸盐结合的理论分析：游离药物与结合药物及治疗水平之间的关系。
Eur J Clin Pharmacol. 1976 Feb 6;9(4):285-90. doi: 10.1007/BF00561662.
6
A chronic dose-ranging kinetic study of salicylate in man [proceedings].人体中水杨酸盐的慢性剂量范围动力学研究[会议论文集]
Br J Pharmacol. 1977 Nov;61(3):456P-457P.
7
Errors in interpretation of data from equilibrium dialysis protein binding experiments.平衡透析蛋白结合实验数据解读中的错误。
Res Commun Chem Pathol Pharmacol. 1979 Oct;26(1):145-60.
8
Concentration dependent plasma protein binding of salicylate in rheumatoid patients.类风湿患者中水杨酸盐的血浆蛋白结合呈浓度依赖性
Clin Pharmacokinet. 1979 Mar-Apr;4(2):137-43. doi: 10.2165/00003088-197904020-00006.
Zotero 插件